Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Neal Biddick, MD

  • 1
    News

    Dose-reduced NOACs may be safer than warfarin in some AFib patients

    October 31, 2019

    Are dose-­reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?

  • 1
    News

    EHR prompt significantly reduced telemetry monitoring during inpatient stays

    October 30, 2019

    Can an EHR prompt reduce the utilization of telemetry monitoring on an inpatient medical service?

  • News

    Short-Course Antimicrobial Therapy Outcomes for Intra-Abdominal Infection

    September 22, 2015

    Clinical question: Does a short, fixed duration of antibiotic therapy for complicated intra-abdominal infections lead to equivalent outcomes and less antibiotic exposure than the traditional approach? Background: Published guidelines recommend appropriate antimicrobial agents for intra-abdominal

  • News

    Post-Procedural Bridging Therapy for Secondary Prevention of VTE Increases Rate of Bleeding

    September 9, 2015

    Research Review: Post-Procedural Bridging Therapy and VTE Prevention

  • News

    Short-Course Antimicrobial Therapy Outcomes for Intraabdominal Infection

    September 9, 2015

    Research Review: Short-Course Antimicrobial Therapy for Intraabdominal Infection

  • News

    Effects of Peri-Operative Beta-Blockade in Noncardiac Surgery Vary Based on Cardiac Risk Factors

    September 9, 2015

    Research Review: Peri-Operative Beta-Blockade in Noncardiac Surgery

  • News

    Risk for In-Hospital Adverse Cardiac Events Low for Some Patients with Chest Pain

    September 9, 2015

    Clinical question: Do stable, low-risk patients hospitalized for chest pain after negative ED evaluation experience adverse cardiac events in the hospital? Background: Chest pain results in more than seven million ED visits annually, with a cost of over $11 billion to hospitalize these patients f

  • News

    New Strategy in Patients with Suspected Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy

    September 9, 2015

    Clinical question: Can a diagnostic strategy that utilizes a clinical prediction rule combined with an immunoassay appropriately guide management for patients with suspected heparin-induced thrombocytopenia (HIT)? Background: The appropriate and timely diagnosis of HIT can decrease the risks of t

  • News

    Vasoactive Medications Safe in ICU via Peripheral Intravenous Access

    September 9, 2015

    Clinical question: Can vasoactive medications be safely given in the ICU via peripheral intravenous (PIV) access instead of central venous access? Background: Vasoactive medications are given to a variety of patients in shock to maintain hemodynamic function.

  • News

    Cost, Frequency of Emergency Department Revisits Evaluated

    September 9, 2015

    Clinical question: What is the cost and frequency of ED revisits within three days and 30 days? Background: ED revisits lead to a financial and resource utilization burden on the medical system.

1 2Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences